Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
about
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other CancersCancer metastases: challenges and opportunitiesMaspin sensitizes prostate cancer cells to doxazosin-induced apoptosisTalin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.Apoptosis induction by doxazosin and other quinazoline alpha1-adrenoceptor antagonists: a new mechanism for cancer treatment?Therapeutic value of quinazoline-based compounds in prostate cancer.Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists.Copper deficiency induced emphysema is associated with focal adhesion kinase inactivationCarvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathwayGrowth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.Advances in the design and synthesis of prazosin derivatives over the last ten years.The prince and the pauper. A tale of anticancer targeted agents.Targeting anoikis resistance in prostate cancer metastasis.An introduction to acinar pressures in BPH and prostate cancer.α-blockade, apoptosis, and prostate shrinkage: how are they related?Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.Antitumor action of α(1)-adrenoceptor blockers on human bladder, prostate and renal cancer cells.Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors.Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.Progesterone Inhibits Endothelial Cell Migration Through Suppression of the Rho Activity Mediated by cSrc Activation.Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.Anti-angiogenic effects and mechanism of prazosin.
P2860
Q26740401-EB02216A-34BB-4579-8266-8E79D6484A15Q28088755-F0D8C25B-3E39-49BB-A495-22ED99F24467Q33218589-19BE058F-638B-48D8-B4F2-89CC783FF228Q33718142-29850901-1E55-4873-B8AE-2A393640D85EQ33746215-17157A65-B1E5-4AD9-9CA7-9B151263A5F0Q33746225-44D4596E-9DE2-4AC6-9360-A3B45096BC75Q34066067-011963DF-7F93-4425-9357-96C93FAD90E0Q34140708-F0CF61AA-1C15-4542-863E-C0FD46690751Q35992390-9ABF4EA4-799D-4170-8323-BD8281FB8849Q36390245-E0E9FE31-1562-4E8A-AA25-F27FD39B8133Q36827500-02BA6EA7-59E7-4297-8A12-76973F6723E5Q37042365-8FF0C895-7349-4B9C-BD0D-3E9C09EB2FAFQ37691830-FA9C4049-283C-4A23-B1BD-D9D49C2CF7CEQ38106624-65470C6D-C002-4372-AEA7-B374B9C2001AQ38191941-C0FE3F46-342A-4576-8BAB-2AEAD829E707Q38793967-346200A2-4BA5-4C26-8228-EEA731DD5697Q39272532-1061F696-EEED-4EC5-9875-811DC6FCFAA2Q40145774-346A132E-975A-488C-A963-23F85EEC52F9Q40329139-00DA7FFE-151A-400C-B585-A85BE7ECB93AQ41260618-16C6E2BC-F366-44BD-BA93-0021077392C3Q41999403-181E3B61-E9FD-4A2B-8F3A-1A27F5E602E9Q53250371-C4903E57-162F-44F6-8DA5-3C21C3116413
P2860
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
@ast
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
@en
type
label
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
@ast
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
@en
prefLabel
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
@ast
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
@en
P2093
P356
P1476
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
@en
P2093
Jason B Garrison
Kaspar Keledjian
Natasha Kyprianou
P2860
P304
P356
10.1002/JCB.20240
P577
2005-02-01T00:00:00Z